Clinical Trials
30 trialsPhase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
SDSR
Boston Children's Hospital
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
Memorial Sloan Kettering Cancer Center
Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)
Fred Hutchinson Cancer Center
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
Mayo Clinic
ExpMACs
Children's Hospital of Philadelphia
Prenatal Transplantation for Fetuses With Fanconi Anemia
Stanford University
Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
M.D. Anderson Cancer Center
A Study of Emapalumab for Pediatric Aplastic Anemia
Memorial Sloan Kettering Cancer Center
HAPLOTAB
Baylor College of Medicine
MATCH
University of Texas Southwestern Medical Center
Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)
Celgene
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
Masonic Cancer Center, University of Minnesota
Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT
Masonic Cancer Center, University of Minnesota
Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC
Children's Hospital of Philadelphia
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Columbia University
ENROL
Hospital Universitari Vall d'Hebron Research Institute
T-cell Depleted Alternative Donor Transplantation
Wake Forest University Health Sciences
Peripheral Blood Stem Cell Transplantation Using the CliniMACS Device
Medical College of Wisconsin
Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
University of California, San Francisco
Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children
Children's Mercy Hospital Kansas City
Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
University of California, San Francisco
Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases
Masonic Cancer Center, University of Minnesota
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
New York Medical College
Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study
Emory University
Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders
University of British Columbia
45RA_NEG_DLI
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation
Rabin Medical Center
Unrelated Donor Transplant for Malignant and Non-Malignant Disorders
Columbia University
Identifying Characteristics of Bone Marrow Failure Syndromes
Office of Rare Diseases (ORD)